Authors
Loading...
This review uncovers cardiovascular disease risks in MASLD patients, suggesting links with metabolic syndrome and fibrotic progression.
Ismail et al. (2025) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: